[4]
Gorain, B.; Choudhury, H.; Pandey, M.; Mohd Amin, M.C.I.; Singh, B.; Gupta, U. Dendrimers as Effective Carriers for the Treatment of Brain Tumor.Nanotechnology-Based Target. Drug Deliv. Syst. Brain Tumors; Elsevier, 2018, pp. 267-305.
[7]
Jones, A.T.; Gumbleton, M.; Duncan, R. Understanding endocytic pathways and intracellular trafficking: a prerequisite for effective design of advanced drug delivery systems. Adv. Drug Deliv. Rev., 2003, 55(2003), 1353-1357.
[8]
Sun, J.; Hee, T.; Yong, K.; Soo, S.; Jin, J. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release. J. Control. Release, 2006, 115(2006), 37-45.
[9]
Hyung, J.; Kwon, S.; Lee, M.; Chung, H.; Kim, J.; Kim, Y. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity. Biomaterials, 2006, 27(2006), 119-126.
[11]
Cao, Y.; Gu, Y.; Ma, H.; Bai, J.; Liu, L.; Zhao, P. Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin. Int. J. Biol. Macromol., 2010, 46(2010), 245-249.
[13]
Shukla, R.; Handa, M.; Lokesh, S.B.; Ruwali, M.; Kohli, K. Conclusion and future prospective of polymeric nanoparticles for cancer therapy, polymer. Nanoparticles as a Promis; Tool Anti-Cancer Ther, 2019, pp. 389-408.
[14]
Sun, L. Peptide Self-assembled nanostructures for drug delivery applications. J. Nanomater., 2017, 16, e4562474
[16]
Gorain, B.; Choudhury, H.; Pandey, M.; Nair, A.B.; Iqbal Mohd Amin, M.C.; Molugulu, N. Dendrimer-based nanocarriers in lung
cancer therapy, nanotechnology-based target. Drug Deliv. Syst.
Lung Cancer, 2019, 161-192.
[21]
Vermant, J.; Grzelczak, M.; Vermant, J.; Furst, E.M.; Liz-marza, L.M. Directed self-assembly of nanoparticles. ACS Nano, 2010, 4, 3591-3605.
[22]
Park, S. Understanding the self-assembly behavior of nanoparticles and polymers. Angew. Chem. Int. Ed., 2007, 119, 9395.
[27]
Shukla, R.; Kumar, J.; Dwivedi, P.; Gatla, P.; Mishra, P.R. Microparticles of diethylcarbamazine citrate for the treatment of lymphatic filariasis. Asian J. Chem., 2013, 25, S302-S304.
[50]
Rigogliuso, S.; Sabatino, M.A.; Adamo, G.; Grimaldi, N.; Dispenza, C.; Ghersi, G. Nanocarriers for drug delivery application. Chem. Eng. Trans., 2012, 27, 247-252.
[66]
Ptorchilin, V. Nanoparticulates as drug carriers. Int. J. Pharm. Investig., 2012, 2(1), 2-11.
[69]
Shukla, R.; Singh, A.; Pardhi, V.; Kashyap, K.; Dubey, S.K.; Dandela, R. Dendrimer-based nanoparticulate delivery system for cancer therapy, polymer. Nanoparticles as a promis; Tool Anti-Cancer Ther, 2019, pp. 233-255.
[71]
Choudhury, H.; Pandey, M.; Gorain, B.; Chatterjee, B.; Madheswaran, T.; Md, S. Nanoemulsions as effective carriers for the treatment
of lung cancer, nanotechnology-based target drug deliv. Syst. Lung
Cancer, 2019, 217-247.
[72]
Gorain, B.; Bhattamishra, S.K.; Choudhury, H.; Nandi, U.; Pandey, M. Overexpressed receptors and proteins in lung cancer, nanotechnology-
based target. Drug Deliv. Syst. Lung Cancer, 2019, 39-75.
[76]
Nagalakshmi, S.; Krishnaraj, K.; Jothy, M.A.; Chaudhari, P.S.; Pushpalatha, H.; Shanmuganthan, S. Fabrication and characterization of herbal drug-loaded nonionic surfactant based niosomal topical gel. J. Pharm. Sci. Res., 2016, 8, 1271-1278.
[83]
Parameshwaran, R.; Sarı, A.; Jalaiah, N.; Karunakaran, R. Applications of thermal analysis to the study of phase-change materials. Handbook Thermal Anal. Calorimet, 2018, 6, 519-572.
[97]
Bolskar, R.D. Fullerenes for drug delivery encyclopedia nanotechnology; Springer Netherlands: Dordrecht, 2016, pp. 1267-1281.
[100]
Bharti, C.; Nagaich, U.; Pal, A.K.; Gulati, N. Mesoporous silica nanoparticles in target drug delivery system: A review. Int. J. Pharm. Investig., 2015, 5(3), 124-133.
[101]
Banik, M.; Basu, T. Calcium phosphate nanoparticles: a study of their synthesis, characterization and mode of interaction with salmon testis DNA. Dalton Trans., 2014, 43(8), 3244-3259.